Related Experiment Video
Updated: May 14, 2026

The Immediate Partial Removal of Cumulus-Oocyte Complexes: A Refined Approach for Rapid Observation of In Vitro Fertilization
Published on: October 18, 2024
[Current position of Essure(®) micro-insert in the management of hydrolsalpinges before in vitro fertilization]
C Sonigo1, P Collinet, C Rubod
1Service de gynécologie endocrinienne et médecine de la reproduction, faculté de médecine de Lille, hôpital Jeanne-de-Flandre, centre hospitalier régional universitaire de Lille, avenue Eugène-Avinée, 59037 Lille cedex, France.
Abstract:
Tubal diseases are a common cause of female infertility. Among them, hydrosalpinges are frequent. In addition, the presence of hydrosalpinges is a factor of failed attempts at in vitro fertilization (IVG). It is now well recognized that the management of hydrosalpinges prior attempts to medically assisted procreation increases the chances of pregnancy. Nowadays, laparoscopic salpingectomy is the treatment of choice but this therapeutic approach is not consensual and several other surgical techniques have been proven in this indication. Among these, the exclusion of hydrosalpinx by laying Essure(®) micro-inserts seems promising. Currently, seven studies have been published on the topic with generally positive results. The purpose of this article is to review the various possible methods to treat hydrosalpinx before IVF and especially to define the role of Essure(®) micro-inserts.
More Related Videos
Related Concept Videos
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Intrauterine Drug Delivery Systems
Birth Control Methods

